Literature DB >> 12665223

Needle revision of failed filtering blebs augmented with subconjunctival injection of mitomycin C.

Guy J Ben-Simon1, Yoseph Glovinsky.   

Abstract

OBJECTIVE: To evaluate the short-term efficacy and safety of needle revision of failed filtering blebs augmented with subconjunctival injection of mitomycin C. PATIENTS AND METHODS: Needle revision of failed filtering blebs followed by subconjunctival injection of 10 to 20 microg of mitomycin C was performed in 41 eyes. Short-term results were analyzed 6 months postoperatively.
RESULTS: The mean (+/- standard deviation [SD]) intraocular pressure decreased from 26.4 +/- 6.2 to 16.4 +/- 6.5 mm Hg (P < .001), and the mean (+/- SD) number of medications decreased from 2.8 +/- 1.4 to 0.7 +/- 1.1 (P < .001). The overall success rate (defined as intraocular pressure between 5 and 21 mm Hg and no serious complications) was 76%. Initial intraocular pressure, number of previous surgical procedures, type of glaucoma, and lens status did not influence the success rate. The resulting bleb was significantly larger in the successful cases (2 +/- 0.8 vs 0.33 +/- 0.5; P < .001). Complications included one case of late suprachoroidal hemorrhage. The mean (+/- SD) visual acuity remained stable (delta visual acuity in Snellen lines = 0.023 +/- 1.1).
CONCLUSION: Needle revision followed by subconjunctival injection of mitomycin C is an alternative to more complicated surgical procedures in cases of failed filtering blebs. Bleb formation was essential for successful reduction of intraocular pressure, which suggests subconjunctival injection of mitomycin C by itself may not lower intraocular pressure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665223

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  7 in total

1.  [Late needling with 5-fluorouracil when scarring of filtering bleb seems imminent].

Authors:  M Müller; S Pape; C Kusserow; H Hoerauf; H Laqua
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

2.  Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines.

Authors:  Justus G Garweg; Maria Wegmann-Burns; David Goldblum
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-10       Impact factor: 3.117

3.  Long-term outcome of mitomycin C-augmented needle revision of trabeculectomy blebs for late trabeculectomy failure.

Authors:  S Lin; D Byles; M Smith
Journal:  Eye (Lond)       Date:  2018-08-29       Impact factor: 3.775

4.  Bleb needling outcomes for failed trabeculectomy blebs in Asian eyes: a 2-year follow up.

Authors:  Andrew S H Tsai; Pui Yi Boey; Hla M Htoon; Tina T Wong
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

5.  Topical Mitomycin-C versus Subconjunctival 5-Fluorouracil for Management of Bleb Failure.

Authors:  Mohammad Pakravan; Arezoo Miraftabi; Shahin Yazdani; Nasim Koohestani; Mehdi Yaseri
Journal:  J Ophthalmic Vis Res       Date:  2011-04

6.  Comparison of Subconjunctival Mitomycin C and 5-Fluorouracil Injection for Needle Revision of Early Failed Trabeculectomy Blebs.

Authors:  Wei Liu; Jianrong Wang; Miaomiao Zhang; Yuan Tao; Yan Sun
Journal:  J Ophthalmol       Date:  2016-02-16       Impact factor: 1.909

7.  Safety and Efficacy of Bleb Needling with Antimetabolite after Trabeculectomy Failure in Glaucoma Patients: A Systemic Review and Meta-Analysis.

Authors:  Xuhao Chen; Lingge Suo; Ying Hong; Chun Zhang
Journal:  J Ophthalmol       Date:  2020-11-30       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.